EKEvgeniy Kreydin

Evgeniy Kreydin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Evgeniy Kreydin has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neurogenic Lower Urinary Tract Dysfunction (NLUTD) in Female Patients: A Comprehensive Clinical Review

    by María P. Molina, Evgeniy I. Kreydin

    Purpose of review: This article reviews the latest American Urological Association (AUA)/Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) guidelines on neurogenic lower urinary tract dysfunction (NLUTD), with a specific focus on implications for obstetricians and gynecologists. It aims to provide a clinically relevant synthesis for OB/GYNs managing women with neurogenic bladder conditions. Recent findings: Recent evidence emphasizes stratified risk assessment, clean intermittent catheterization (CIC) as a protective standard, and early identification of high-risk features such as poor bladder compliance and detrusor-sphincter dyssynergia. New insights also highlight obstetric complications, autonomic dysreflexia, and the utility of neuromodulation and botulinum toxin in selected patients. Summary : Effective multidisciplinary care for women with NLUTD requires familiarity with current guidelines. OB/GYNs play a vital role in pregnancy counseling, perioperative care, and bladder health maintenance. Integration of urologic principles into gynecologic practice can improve patient outcomes, reduce complications, and support reproductive goals in this population.

  • Open Access

    The Current Epidemiology of Urinary Incontinence and Urinary Tract Infections After Spinal Cord Injury—A Model Systems Spinal Cord Injury Examination (2016–2021)

    by Christopher Elliott, Evgeniy Kreydin, James Crew, Kazuko Shem

    Introduction: Neurogenic bladder disorders after spinal cord injury (SCI) are often problematic with urinary incontinence (UI) and recurrent urinary tract infections (UTIs) contributing to patient morbidity. Our study objective was to provide a current snapshot of the frequency of UI and UTIs in the SCI population while also quantifying their association with hospitalization. Methods: The National Spinal Cord Injury Database (2016–2021) was accessed for persons within five years of injury. The self-reported frequency of UI in the last month (none, daily, weekly, monthly), the number of UTIs requiring antibiotic treatment, and the number of hospitalizations (including reason) in the prior year were evaluated. Results: Our cohort comprised 5106 individuals within 5 years of SCI. Approximately 40% reported UI in the past month and over 50% had a UTI requiring antibiotics in the past year. Incontinence was significantly more frequent in those performing clean intermittent catheterization (CIC) (52% overall, 17% daily) compared to indwelling catheters (29% overall) or volitional void (22% overall) (p < 0.001 for each). Conversely, UTIs were most common in those using indwelling catheters (79% with at least one UTI) or CIC (70%) compared to diapers/condom catheters (46%) or volitional void (19%) (p < 0.001 for each). Increasing UI and UTI occurrences were both associated with an increased frequency of hospitalization in the prior year. Conclusions: UI and UTIs are common problems after SCI. While differing frequencies of UI and UTI are present based on bladder management, the overall frequency suggests that a continued emphasis on prevention is needed to potentially increase quality of life and decrease hospitalization.


  • Open Access

    Novel and Established Neuroimaging Modalities in Neurogenic Lower Urinary Tract Dysfunction

    by Nhi Ha, Mohammad Z. Khan, Priya Kohli, Petr Gaburak, Yusen Wang, Aidin Abedi, Evgeniy Kreydin

    Purpose of Review: Neurogenic lower urinary tract dysfunction (NLUTD) is a condition characterized by bladder or urinary sphincter control issues due to neurologic dysregulation. NLUTD commonly causes symptoms like urinary incontinence and retention that impact both urinary health and quality of life. Current NLUTD treatment primarily manages symptoms, as restorative interventions are limited by a lack of diagnostic approaches to understand its underlying neurologic mechanisms. Neuroimaging may help identify neurologic pathways associated with bladder control, providing insights into functional and structural neural changes in NLUTD. This report reviews current neuroimaging modalities and their efficacy in detecting NLUTD. Recent Findings: Evaluated modalities include functional magnetic resonance imaging, positron emission tomography, functional near-infrared spectroscopy, functional ultrasonography, electrocorticography, and deep brain stimulation. Each modality’s unique characteristics, such as resolution and invasiveness, shape its application in studying neurologic mechanisms of NLUTD. Collectively, they reveal a consistent finding: reduced brain activation in circuits related to bladder voiding and storage in patients with NLUTD. Summary: By examining each method’s mechanism, effectiveness, advantages, and limitations, we aim to aid clinicians and researchers in selecting the best techniques for exploring the mechanisms of NLUTD and developing restorative treatments.


  • Resilience as an Independent Predictor of Bowel Related Quality of Life After Spinal Cord Injury

    by Aidin Abedi, Stefania Montero, Luis Alejandro Morales Ojeda, Petr Gaburak, Priya Kohli, Armita Abedi, David Chapman, David Ginsberg, Evgeniy Kreydin

    Bowel dysfunction remains a prominent priority in the rehabilitation of patients with spinal cord injuries (SCIs). However, our understanding of the factors that influence bowel-related quality of life (QoL) in this population remains limited. This study aimed to investigate the potential role of resilience, defined as an individual's capacity to cope with and adapt to adversity, as a predictor of bowel-related QoL among the patients with SCI. A cohort of adult patients with SCI who received bowel and bladder care at an outpatient clinic within a large rehabilitation hospital was identified through a prospectively collected database. Resilience was measured using the Spinal Cord Injury-Quality of Life (SCI-QOL) Resilience Short Form, whereas bowel QoL was assessed using the Irritable Bowel Syndrome-Quality of Life (IBS-QoL) questionnaire. Univariate and multivariate regression analyses were employed to identify predictors of bowel-related QoL. The examined variables included age, gender, level and completeness of injury, time since injury, hand function, resilience, and the severity of bowel dysfunction as measured using the Neurogenic Bowel Dysfunction Score (NBDS). A total of 73 patients participated in this study, with a mean age of 44.01 ± 13.43 years and comprising mostly men ( n = 57, 78%). The results revealed a significant correlation between resilience scores and the total score of IBS-QoL ( ρ = -0.47, p < 0.0001). The multivariate analysis demonstrated that both resilience and the severity of bowel dysfunction were significant independent predictors of bowel-related QoL, with resilience demonstrating a stronger association. Overall, this study elucidates the importance of resilience in shaping patients' perceptions of their bowel health within the SCI population. In addition to the more expected determinants of bowel-related QoL, such as the severity of bowel dysfunction, resilience emerged as a notable factor. Accordingly, integrating interventions that enhance resilience within bowel rehabilitation programs may yield improvements in patients' perceived bowel health beyond the benefits achievable through bowel function enhancement alone.


  • Open Access

    Content, face, and construct validity of the Irritable Bowel Syndrome Quality of Life (IBS‐QOL) as a measure of bowel‐related quality of life in spinal cord injury

    by Aidin Abedi, Priya Kohli, Stefania Montero, Luis Morales, Nhi Ha, Armita Abedi, Anibal La Riva, David Ginsberg, Evgeniy Kreydin

    Introduction: Neurogenic bowel dysfunction is commonly encountered after a spinal cord injury (SCI), leading to a tremendous impact on quality of life (QOL). The neurogenic bowel dysfunction score (NBDS) is commonly used to measure the severity of bowel dysfunction and predict QOL. However, there is no comprehensive instrument to assess bowel‐specific QOL for SCI patients. Instead, the Irritable Bowel Syndrome‐Quality of Life (IBS‐QOL) questionnaire evaluates the impact of bowel dysfunction on several aspects of QOL, although this questionnaire has not been validated for the SCI population. Motivated by the compelling need of instruments to accurately evaluate the QOL in patients who develope NBD after SCI, we aimed to assess the construct, content, and face validity of IBS‐QOL in this population.Methods: Adult SCI patients with at least 3 months after their injury were recruited from the outpatient clinic of a national rehabilitation hospital. Patients completed the NBDS and IBS‐QOL via telephone interview or paper survey in the clinic. Content and face validity were assessed via interviews with professionals with expertise in providing chronic care for SCI, as well as a subgroup of patients. Construct validity was assessed using the hypotheses testing method. Internal consistency was assessed using Cronbach's ⍺. Factor analysis was performed to assess the dimensionality of the IBS‐QOL in the SCI population.Results: A total of 106 patients with a median age of 45.5 years (interquartile range: 21–79) participated in the study. The majority of the sample were men (n = 82, 77%) and had endured thoracolumbar injuries (n = 74, 71.2%). Twelve patients (seven English‐ and five Spanish speakers) and six professionals took part in content/face validation interviews. The median IBS‐QOL total score was 15.91/100 (interquartile range: 4.55–33.14). IBS‐QOL differentiated the subgroups of patients with severe bowel symptoms in terms of uneasiness, sweating, or headaches during bowel emptying (p = 0.0003), time spent on bowel emptying (p = 0.0065), flatus incontinence (p = 0.0076), and overall satisfaction with bowel function (p < 0.001), demonstrating its adequate construct validity. Interviews with the patients and professionals supported the comprehensiveness, comprehensibility, and relevance of IBS‐QOL for assessment of bowel‐related QOL in the SCI population. Item‐level analysis of professional responses showed that 97% of questions were relevant to the construct and population of interest. Internal consistency analysis yielded a Cronbach's ⍺ of 0.9684. Exploratory factor analysis yielded six underlying factors which cumulatively accounted for 72.21% of the total variance, reflecting the dimensionality of bowel‐related QOL in SCI population.Discussion: IBS‐QOL questionnaire is a comprehensive measure of bowel‐related QOL which encompasses the concerns of SCI patients. Our findings support the content, face and construct validity of IBS‐QOL as a measure of bowel‐related QOL in SCI. Further studies are warranted to assess the reliability and responsiveness of IBS‐QOL, and to evaluate its performance across different patient populations.


  • Editorial Comment

    by Mitchell Goldenberg, Rita Jen, Evgeniy I. Kreydin

  • Open Access

    Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder

    by Hui Zhong, Emilie Liu, Priya Kohli, Laura Perez, V. Reggie Edgerton, David Ginsberg, Parag Gad, Evgeniy Kreydin

    Background: Overactive bladder (OAB) affects 12 to 30% of the world’s population. The accompanying urinary urgency, frequency and incontinence can have a profound effect on quality of life, leading to depression, social isolation, avoidance of sexual activity and loss of productivity. Conservative measures such as lifestyle modification and pelvic floor physical therapy are the first line of treatment for overactive bladder. Patients who fail these may go on to take medications, undergo neuromodulation or receive injection of botulinum toxin into the bladder wall. While effective, medications have side effects and suffer from poor adherence. Neuromodulation and botulinum toxin injection are also effective but are invasive and not acceptable to some patients. Methods: We have developed a novel transcutaneous spinal cord neuromodulator (SCONE™,) that delivers multifrequency electrical stimulation to the spinal cord without the need for insertion or implantation of stimulating electrodes. Previously, multifrequency transcutaneous stimulation has been demonstrated to penetrate to the spinal cord and lead to motor activation of detrusor and external urethral sphincter muscles. Here, we report on eight patients with idiopathic overactive bladder, who underwent 12 weeks of SCONE™ therapy. Results: All patients reported statistically significant clinical improvement in multiple symptoms of overactive bladder, such as urinary urgency, frequency and urge incontinence. In addition, patients reported significant symptomatic improvements as captured by validated clinical surveys. Conclusion: SCONE™ therapy represents the first of its kind therapy to treat symptoms of urgency, frequency and urge urinary incontinence in patients with OAB. Trial registration: The study was listed on clinicaltrials.gov (NCT03753750).


  • The Association of Physical Activity and Urinary Incontinence in US Women: Results from a Multi-Year National Survey

    by Michelle M. Kim, Seyedeh-Sanam Ladi-Seyedian, David A. Ginsberg, Evgeniy I. Kreydin